In this articile, a case with MGUS due to chronic osteomyelitis was reported.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Monoclonal gammapathy was detected in a patient who had been operated four times for osteomiyelitis in her foot and had taken antituberculoid drugs for three years.
📊
Key Findings & Data:Her clinical and laboratory findings corresponded with monoclonal gammapathy of undetermined significance (MGUS).
💡
Conclusion & Impact:In this articile, a case with MGUS due to chronic osteomyelitis was reported.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Monoclonal gammapathy was detected in a patient who had been operated four times for osteomiyelitis in her foot and had taken antituberculoid drugs for three years. Her clinical and laboratory findings corresponded with monoclonal gammapathy of undetermined significance (MGUS). In this articile, a case with MGUS due to chronic osteomyelitis was reported.
Özet
Ayağındaki osteomiyelit nedeni ile dört kez operasyon geçiren ve 3 yıl süre antitüberküloz ilaç kullanan bir hastada monoklonal gamopati saptandı. Klinik ve laboratuar özellikleri ile önemi bilinmeyen monoklonal gamopati (ÖBMG) ile uyumlu idi. Bu yazıda kronik osteomiyelit sonrası ortaya çıkan bir ÖBMG olgusu sunulmaktadır.
🔖
Cite This Article
ŞENTÜRK, T., BOLAMAN, A. Z., YAVAŞOĞLU, İ., KADIKÖYLÜ, G. (2022). Monoclonal gammapathy of undetermined significence due to chronic osteomyelitis (A case report). Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 1 - Sayı: 2, 39–41. https://ajindex.com/articles/429173
Kyle RA, Rajkumar SV. Monoclonal gammopathies and related disorders.Hematology- Oncology Clinics of North America 1999
Durie BGM. Staging and kinetics of multiple myeloma. Semin Oncol 1986
Greipp PR. Advances in the diagnosis and management of myeloma. Semin Hematol 1992
29 (suppl 2):24-45. 4.Baldini L, Guffanti A, Cesana BM, Colombi M, Chiorboli O, Damilano I, Maiolo AT. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Blood 1996
Greipp PR, Witzig TE, Gonchoroff NJ, Habermann TM, Katzmann JA,O' Fallon WM, Kyle RA. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies. Mayo Clinc Proc 1987
Cohen HJ, Bernstein RJ, Grufferman S. Role of immune stimulation in the etiology of multiple myeloma: a case central study. American Journal of Hematology 1987
Linet MS, Harlow SD, Mc Laughlin JK. A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation and drug use. Cancer Research 1987
Osserman EF, Takatsuki K. Plasma cell myeloma: Gammaglobulin synthesis and structure. Medicine 1963
Foerster J. Plasma cell dyscrasias: general considerations. In: Wintrobe's Clinical Hematology. Lee R, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM (Edits). 10thEd., Williams& Wilkins, Mass Publishing Co, Mısır, 1999
Kyle RA. Monoclonal gammopathy of undetermined significance. Blood Reviews 1994
Tricot G. Multiple myeloma and other plasma cell disorders. In: Hematology. Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, Mc Glave P (Edits). 3rd Ed., Churchill Livingstone, Philedelphia, 2000
Chelazzi G, Senaldi G. Serum Beta-2 microglobulin levels in multiple myeloma and monoclonal gammopathy of undetermined significance: a clinical study of 55 patients. Ric Clin Lab 1986
Zhang XG, Bataille R, Widjeners J, Klein B. Interleukin 6 dependence of advanced malignant plasma cell dyscrasias. Cancer 1992
Kyle RA. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Hematology Oncology Clinics of North America 1997
Witzig TE. The role of adhesion receptors in the pathogenesis of multiple myeloma.Hematology Oncology Clinic